https://www.marketscreener.com/quote/stock/CELLDEX-THERAPEUTICS-INC-54658351/news/Celldex-Therapeutics-Inc-Announces-Completion-of-Enrollment-in-Phase-2-Study-of-Barzolvolimab-in-P-46457448/?utm_source=telegram&utm_medium=social&utm_campaign=share